BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38468267)

  • 1. The RNA sequencing results revealed the expression of different genes and signaling pathways during chemotherapy resistance in peripheral T-cell lymphoma.
    Lan Y; Tao W; Ma L; Wang X; Li H; Du Y; Yang R; Wu S; Ou Y; Liu X; Huang Y; Zhou Y
    BMC Med Genomics; 2024 Mar; 17(1):74. PubMed ID: 38468267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer.
    Bao Y; Wang L; Shi L; Yun F; Liu X; Chen Y; Chen C; Ren Y; Jia Y
    Cell Mol Biol Lett; 2019; 24():38. PubMed ID: 31182966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Hub Genes and Key Pathways Associated with Peripheral T-cell Lymphoma.
    Gao HX; Wang MB; Li SJ; Niu J; Xue J; Li J; Li XX
    Curr Med Sci; 2020 Oct; 40(5):885-899. PubMed ID: 32980897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gene expression profile and cell of origin of canine peripheral T-cell lymphoma.
    Owens E; Harris L; Harris A; Yoshimoto J; Burnett R; Avery A
    BMC Cancer; 2024 Jan; 24(1):18. PubMed ID: 38166662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma.
    Zhang P; Zhang M
    Clin Epigenetics; 2020 Nov; 12(1):169. PubMed ID: 33160401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA-seq and Network Analysis Reveal Unique Chemokine Activity Signatures in the Synovial Tissue of Patients With Rheumatoid Arthritis.
    Zhang R; Jin Y; Chang C; Xu L; Bian Y; Shen Y; Sun Y; Sun S; Schrodi SJ; Guo S; He D
    Front Med (Lausanne); 2022; 9():799440. PubMed ID: 35602512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Throughput Sequence Analysis of Peripheral T-Cell Lymphomas Indicates Subtype-Specific Viral Gene Expression Patterns and Immune Cell Microenvironments.
    Nakhoul H; Lin Z; Wang X; Roberts C; Dong Y; Flemington E
    mSphere; 2019 Jul; 4(4):. PubMed ID: 31292228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressions.
    Meng Y; Quan L; Liu A
    Gene; 2018 Feb; 642():205-211. PubMed ID: 29128636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA Sequencing for Gene Expression Profiles in Peripheral Blood Mononuclear Cells with Ankylosing Spondylitis RNA.
    Huang D; Liu J; Cao Y; Wan L; Jiang H; Sun Y; Wen J
    Biomed Res Int; 2020; 2020():5304578. PubMed ID: 32596323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-positive nodal peripheral T cell lymphomas: clinicopathologic and gene expression profiling study.
    Ha SY; Sung J; Ju H; Karube K; Kim SJ; Kim WS; Seto M; Ko YH
    Pathol Res Pract; 2013 Jul; 209(7):448-54. PubMed ID: 23735590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical outcomes of patients with peripheral T-cell lymphoma (PTCL) treated by EPOCH regimen].
    Peng YL; Huang HQ; Lin XB; Xia ZJ; Li YH; Wang W; He YJ; Pan ZH; Jiang WQ; Guan ZZ
    Ai Zheng; 2004 Aug; 23(8):943-6. PubMed ID: 15301720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic challenges in peripheral T-cell lymphoma.
    Luan Y; Li X; Luan Y; Luo J; Dong Q; Ye S; Li Y; Li Y; Jia L; Yang J; Yang DH
    Mol Cancer; 2024 Jan; 23(1):2. PubMed ID: 38178117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical significance of activated p-AKT expression in peripheral T-cell lymphoma.
    Hong JY; Hong ME; Choi MK; Chang W; Do IG; Jo JS; Jung SH; Park S; Kim SJ; Ko YH; Kim WS
    Anticancer Res; 2015 Apr; 35(4):2465-74. PubMed ID: 25862915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-Generation Sequencing Analysis of mRNA Profile in Cisplatin-Resistant Gastric Cancer Cell Line SGC7901.
    Deng Z; Wang H; Guo G; Li X; Cai Y; Tang Y; Wang Y; Li J; Lu Z; Yu X; Li R; Li L
    Med Sci Monit; 2019 Apr; 25():2386-2396. PubMed ID: 30938333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression profiling of microRNA and their target genes in peripheral T cell lymphoma, not otherwise specified].
    Li M; Lü N; Liu HX; Chen DB; Zhang JZ
    Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):519-24. PubMed ID: 24246916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Key Gene and Functional Pathways Identified in Unexplained Recurrent Spontaneous Abortion Using Targeted RNA Sequencing and Clinical Analysis.
    Gu H; Li L; Du M; Xu H; Gao M; Liu X; Wei X; Zhong X
    Front Immunol; 2021; 12():717832. PubMed ID: 34421922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole Transcriptomic Analysis of Key Genes and Signaling Pathways in Endogenous ARDS.
    Xie Y; Luo J; Hu W; Ye C; Ren P; Wang Y; Li X
    Dis Markers; 2022; 2022():1614208. PubMed ID: 36246560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of microRNA-messenger RNA regulatory network in gemcitabine-resistant bladder cancer cells.
    Zhang S; Chang YY; Gong YW; Gao YJ; Guo Q; Wang YH; Zhao YL; Wang ZP
    J Cell Biochem; 2019 Apr; 120(4):6347-6360. PubMed ID: 30304549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.